Skip to main content

Drugs, Birth, and Ethics

  • Chapter
  • 113 Accesses

Part of the book series: Contemporary Issues in Biomedicine, Ethics, and Society ((CIBES))

Abstract

When fetal organs are developing, exposure to many drugs and other substances may produce behavioral, neurological, and structural changes. These agents are called teratogens when they produce physical changes and behavioral teratogens when they produce behavioral changes with or without accompanying physical changes. Figure 1 shows, for a rat fetus, the limited periods during embryogenesis when it is susceptible to physical deformity and the longer period, preceding and following birth, when the animal is vulnerable to central nervous system damage. In human beings, the period of vulnerability to central nervous system damage from exposure to drugs and chemicals lasts much longer. Even after birth, important areas of brain are growing and differentiating at a rapid rate and are still, therefore, especially vulnerable to damage. It has been estimated that the “growth spurt” in the cerebellum lasts for about 18 months, and that in the hippocampus, for about 4.5 years.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Gottlieb, G., ed., Studies on the Development of Behavior and the Nervous System, vol. 4, Early Influences, Academic, New York (1976).

    Google Scholar 

  • Mofenson, H. C., J. Greensher, and R. Horowitz, Hazards of Maternally Administered Drugs, Clin. Toxicol. 7, 59 (1974).

    Article  Google Scholar 

  • Schardein, J. L., Drugs as Teratogens, Chemical Rubber Co., Cleveland, 1976.

    Google Scholar 

  • Shepard, T. H., Catalog of Teratogenic Agents, 2nd ed., The Johns Hopkins University Press, Baltimore, 1976.

    Google Scholar 

  • Stewart, R. B., L. E. Cluff, and J. R. Philp, eds., Drug Monitoring: A Requirement for Responsible Drug Use, Baltimore, Williams & Wilkins, 1977.

    Google Scholar 

  • Warkany, J., Congenital Malformation, Yearbook Medical, Chicago, 1975.

    Google Scholar 

  • Wilson, J. G., and F. C. Fraser, eds., Handbook of Teratology, vol. 4, Plenum, New York, 1977.

    Google Scholar 

Download references

Authors

Editor information

Helen B. Holmes Betty B. Hoskins Michael Gross

Rights and permissions

Reprints and permissions

Copyright information

© 1980 Humana Press Inc.

About this chapter

Cite this chapter

Brackbill, Y. (1980). Drugs, Birth, and Ethics. In: Holmes, H.B., Hoskins, B.B., Gross, M. (eds) Birth Control and Controlling Birth. Contemporary Issues in Biomedicine, Ethics, and Society. Humana Press. https://doi.org/10.1007/978-1-4612-6005-9_23

Download citation

  • DOI: https://doi.org/10.1007/978-1-4612-6005-9_23

  • Publisher Name: Humana Press

  • Print ISBN: 978-0-89603-023-7

  • Online ISBN: 978-1-4612-6005-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics